MFDS Conducts Comprehensive Survey of 382 Digital Medical Device Companies
Cardiovascular Diseases Account for 42.3%, Rehabilitation for 37.2%

The digital medical device market has been found to be centered around diagnostic assistance services. However, about half of the companies are experiencing difficulties in securing specialized personnel, making regulatory support for licensing and fostering talent key challenges for the future growth of the industry.


The Ministry of Food and Drug Safety conducted a comprehensive survey for the first time since the implementation of the Digital Medical Products Act, targeting 382 companies that have either transitioned to or newly entered the digital medical device market. The results of the "2025 Digital Medical Device Market Status Survey" were released on June 12.


This survey was conducted to comprehensively understand the market size of the digital medical device industry, as well as the current status of companies, employment, and trade structure, in order to establish a basic statistical foundation necessary for policy development and regulatory improvement.

Digital Medical Devices Grow Around Diagnostics... Licensing Challenges Intensify View original image

Last year, diagnostic assistance accounted for the largest share of digital medical device companies' main service areas at 35.8%, followed by testing (26.6%), information provision and management (15.3%), and treatment (12.4%). The main disease categories targeted were cardiovascular diseases, which accounted for the highest proportion at 42.3%, followed by rehabilitation at 37.2%, cancer at 29.6%, mental health at 23.4%, and diabetes at 19.3%.


The testing field was concentrated on cardiovascular diseases (46.6%) and rehabilitation (39.7%), while the diagnostic assistance field had a high proportion of cardiovascular diseases (48.0%) and cancer (34.7%). In the treatment field, rehabilitation-related products took the largest share at 52.9%, indicating that the market is focused on chronic disease management.


The workforce structure is characterized by a focus on young professionals and research and development roles. Among employees in the digital medical device sector, those aged 30-39 accounted for the largest proportion at 38.9%, followed by those aged 40-49 at 27.7%, and those under 29 at 18.3%. By job function, research and development personnel made up the largest share at 33.3%, while procurement and sales staff accounted for 19.7%.


However, securing talent has been identified as a major challenge. 48.9% of companies responded that staffing is difficult. The most common reason cited was a "lack of specialized and skilled personnel in the field" at 63.4%, followed by a "shortage of personnel with the required academic background" at 14.2%.


The main export destination was Southeast Asia, accounting for 64.4%. This was followed by North America at 37.3%, and Central/West Asia and Northern/Western Europe at 32.2% each. In contrast, the main import regions were Northern/Western Europe at 63.3% and North America at 60.0%, indicating a high dependence on advanced countries. As for countries companies hope to export to in the future, Japan ranked first at 35.6%.


The most commonly cited difficulty in the export process was "challenges with export procedures and documentation," at 45.8%. This was followed by "differences in regulations, systems, and culture in local countries" and "lack of information about local markets and customers," each at 44.1%, and "lack of funding" at 32.2%.


Demand for regulatory support to vitalize business was focused on licensing. 85.4% of respondents said that support related to medical device licensing was necessary, followed by 62.4% for "regulatory standards for AI-applied products" and 48.5% for "new medical technology assessment and insurance reimbursement."



The Ministry of Food and Drug Safety stated, "We will continue to pursue policies based on industry demand, such as regulatory support for licensing, and use the results of this digital medical device market status survey as evidence for policy making in the future."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing